So far, several GWASs have been conducted on various AD biomarkers, such as Aβ, tau protein, phosphorylated tau protein, and sTREM concentrations of cerebrospinal fluid (CSF), which has led to the discovery of novel genes and pathways involved in AD [34, 35]. The gene discussed is MAPT; the disease is Alzheimer disease.